Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Retinitis Pigmentosa (Complet Panel) , Panel Massive Sequencing (NGS) 57 Genes Reference Laboratory Genetics Spain | 57 | 57 |
|
Autosomal Dominant Retinitis Pigmentosa, Panel Massive Sequencing (NGS) 27 Genes Reference Laboratory Genetics Spain | 26 | 27 |
|
Autosomal Recessive and Sporadic Retinitis Pigmentosa, Panel Massive Sequencing (NGS) 41 Genes Reference Laboratory Genetics Spain | 41 | 41 |
|
RETINITIS PIGMENTOSA (AUTOSOMAL DOMINANT) Laboratorio de Genetica Clinica SL Spain | 7 | 7 |
|
Retinitis Pigmentosa NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 103 | 92 |
|
Retinitis Pigmentosa, Sequencing RP1 Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Eye diseases comprehensive panel Asper Biogene Asper Biogene LLC Estonia | 367 | 291 |
|
CeGaT GmbH Germany | 1 | 1 |
|
Molecular Vision Laboratory United States | 372 | 283 |
|
Retinitis pigmentosa, autosomal recessive and X-linked Panel CeGaT GmbH Germany | 37 | 62 |
|
Retinitis pigmentosa, autosomal dominant and X-linked Panel CeGaT GmbH Germany | 24 | 30 |
|
Institute of Human Genetics Medical University Innsbruck Austria | 1 | 1 |
|
Fulgent Genetics United States | 1 | 1 |
|
Autosomal Dominant Retinitis Pigmentosa Asper Biogene Asper Biogene LLC Estonia | 25 | 26 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Retinitis Pigmentosa NGS Panel Fulgent Genetics United States | 329 | 124 |
|
MedGene Slovakia | 1 | 1 |
|
Autosomal Recessive Retinitis Pigmentosa Asper Biogene Asper Biogene LLC Estonia | 57 | 56 |
|
Comprehensive Eye Disorders NGS Panel Fulgent Genetics United States | 1018 | 459 |
|
Praxis fuer Humangenetik Wien Austria | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.